
FORW.PHARMA ADR/14 
 Depository Receipt · US34986J2042  · FWP  · A2PV5H  (XNCM)
                    No Price
                
            n/a
        
        Company Profile for FORW.PHARMA ADR/14 Depository Receipt
    
 Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
 Company Data
Name FORW.PHARMA ADR/14
 Company Forward Pharma A/S
 Symbol FWP
 Website 
                            https://www.forward-pharma.com
                        
 Primary Exchange 
                        NASDAQ CAPITAL MARKET
                    
 WKN A2PV5H
 ISIN US34986J2042
 Asset Class Depository Receipt
     Sector Healthcare
 Industry Biotechnology
 CEO Claus Svendsen
  Country Denmark
 Currency EUR
 Employees 0,0 T
 Address Oestergade 24A, 1, Copenhagen K, 1100 Koebenhavn K
 IPO Date 2014-10-15
Ticker Symbols
| Name | Symbol | 
|---|---|
| NASDAQ | FWP | 
            More Shares
            
 
                Investors who hold FORW.PHARMA ADR/14 also have the following shares in their portfolio:
            
            The financial platform MoneyPeak tracks and analyzes investments and portfolios.
 From securities portfolios to crypto purchases.
            
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
 Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



